Bone Marrow-Derived Cell Transplantation Therapy for Myocardial Infarction: Lessons Learned and Future Questions
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bone Marrow-Derived Cell Transplantation Therapy for Myocardial Infarction: Lessons Learned and Future Questions
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume 11, Issue 11, Pages 2297-2301
Publisher
Wiley
Online
2011-09-20
DOI
10.1111/j.1600-6143.2011.03750.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intramyocardial Stem Cell Injection in Patients With Ischemic Cardiomyopathy
- (2011) Adam R. Williams et al. CIRCULATION RESEARCH
- Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy
- (2011) David M. Leistner et al. Clinical Research in Cardiology
- Age, gender and diabetic status are associated with effects of bone marrow cell therapy on recovery of left ventricular function after acute myocardial infarction: A systematic review and meta-analysis
- (2010) Yongyi Bai et al. AGEING RESEARCH REVIEWS
- Cell-based therapy for myocardial repair in patients with acute myocardial infarction: Rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI)
- (2010) Daniel Sürder et al. AMERICAN HEART JOURNAL
- CD34+ cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent
- (2010) Arshed A. Quyyumi et al. AMERICAN HEART JOURNAL
- Bone marrow mononuclear cells reduce myocardial reperfusion injury by activating the PI3K/Akt survival pathway
- (2010) Matthew J. Lovell et al. ATHEROSCLEROSIS
- Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and Differentiation
- (2010) Konstantinos E. Hatzistergos et al. CIRCULATION RESEARCH
- Mesenchymal Stem Cells for Cardiac Cell Therapy
- (2010) Yeong-Hoon Choi et al. HUMAN GENE THERAPY
- Red Blood Cell Contamination of the Final Cell Product Impairs the Efficacy of Autologous Bone Marrow Mononuclear Cell Therapy
- (2010) Birgit Assmus et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of Timing on Efficacy and Safetyof Intracoronary Autologous Bone Marrow Stem Cells Transplantation in Acute Myocardial Infarction: A Pooled Subgroup Analysis of Randomized Controlled Trials
- (2009) Shuning Zhang et al. CLINICAL CARDIOLOGY
- Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial
- (2009) G. P. Meyer et al. EUROPEAN HEART JOURNAL
- Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction
- (2009) Kang Yao et al. EUROPEAN JOURNAL OF HEART FAILURE
- Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease
- (2009) Susan J. Brunskill et al. EUROPEAN JOURNAL OF HEART FAILURE
- Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-derived stem cells after thrombolytic therapy
- (2009) J. A Miettinen et al. HEART
- Promise of Blood- and Bone Marrow-Derived Stem Cell Transplantation for Functional Cardiac Repair
- (2009) Thorsten Reffelmann et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction
- (2009) Joshua M. Hare et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study
- (2008) Mariann Gyöngyösi et al. Nature clinical practice. Cardiovascular medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started